Table 1 Clinicopathological characteristics of patients with breast cancer.
Characteristics | Luminal A (n = 17) | Luminal B (n = 42) | Triple negative (n = 14) | Her2 (n = 5) |
|---|---|---|---|---|
Age (years) | ||||
< 40 | 0 (0) | 2 (4.8) | 3 (21.4) | 0 (0) |
40–49 | 1(5.9) | 5 (11.9) | 2 (14.3) | 1 (20.0) |
50–65 | 7 (41.2) | 18 (42.9) | 7 (50) | 1 (20.0) |
> 65 | 9 (52.9) | 17 (40.5) | 2 (14.3) | 3 (60.0) |
Lymph nodes | ||||
Negative | 12 (70.6) | 19 (45.2) | 8 (57.1) | 2 (40.0) |
Positive | 3 (17.6) | 22 (52.4) | 6 (42.9) | 2 (40.0) |
Unknown | 2 (11.8) | 1 (2.4) | 0 (0) | 1 (20.0) |
TNM State (AJCC) | ||||
I | 2 (11.8) | 6 (14.3) | 1 (7.1) | 0 (0) |
II | 14 (82.4) | 16 (38.1) | 3 (21.4) | 1 (20.0) |
III | 0 (0) | 18 (42.9) | 10 (71.4) | 3 (60.0) |
IV | 0 (0) | 2 (4.8) | 0 (0) | 1 (20.0) |
Unknown | 1 (5.9) | 0 (0) | 0 (0) | 0 (0) |
ER | ||||
Negative | 0 (0) | 0 (0) | 14 (100) | 5 (100) |
Positive | 17 (100) | 42 (0) | 0 (0) | 0 (0) |
PR | ||||
Negative | 0 (0) | 8 (19.0) | 14 (100) | 5 (100) |
Positive | 17 (100) | 34 (81.0) | 0 (0) | 0 (0) |
HER2 | ||||
Negative | 16 (94.1) | 33 (78.6) | 14 (100) | 0 (0) |
Positive | 1 (5.9) | 9 (21.4) | 0 (0) | 5 (100) |
Ki67 | ||||
< 15% | 17 (100) | 1 (2.4) | 0 (0) | 1 (20.0) |
> 15% | 0 (0) | 41 (97.6) | 13 (92.9) | 3 (60.0) |
Unknown | 0 (0) | 0 | 1 (7.1) | 1 (20.0) |
NAT before surgery | ||||
No NAT | 14 (82.4) | 32 (76.2) | 4 (28.6) | 1 (20.0) |
AC | 2 (11.8) | 0 (0) | 2 (14.3) | 1 (20.0) |
TX | 0 (0) | 2 (4.8) | 1 (7.1) | 3 (60.0) |
AC + TX | 1 (5.9) | 8 (19.0) | 6 (42.9) | 0 (0) |
FEC + TX | 0(0) | 0 (0) | 1 (7.1) | 0 (0) |
